A concise analysis of innovative anticancer drugs approved by FDA in 1999- 2014
Alita;WU Zhi-ang;Shenyang Pharmaceutical University;Institute of Medical Informatics;Chinese Academy of Medical Science;

..............page:1081-1090

The lesson of failure is more reliable than successful experience in developing new drugs
LI Feng-jie;LI Lian-da;LI Yi-kui;The Academician Research Laboratory of Lilianda;Xiyuan Hospital CACMS;

..............page:1091-1092

Inspiration of India “Delhi”mode to realize the goals of national essential drug system
WANG Dan-ping;First Affiliated Hospital of Xiamen University;

..............page:1093-1095

Systematic introduction about clinical research management of HMS DF / HCC: entire process management of clinical research
CAO Ye;The Department of Clinical Research /National Clinical Trials Institute;Sun Yat-sen Univerisity Cancer Center;

..............page:1096-1099

Development and suggestion of biosimilar monoclonal antibody
WANG You-fu;YUAN Xi-bin;ZHANG Juan;School of Life Science & Technology;China Pharmaceutical University;Shanghai Shyndec Pharmaceutical Co.;Ltd.;

..............page:1100-1104

Key technical points in clinical trial design of the new drugs of traditional Chinese medicine for the treatment of stroke
LIU Bing-lin;Center for Drug Evaluation;China Food and Drug Administration;

..............page:1105-1107+1127

Influences on intestinal absorption of(- )-Syringaresinol-4-O-β-Dapiofuranosyl-( 1→2)-β-D-glucopyranoside in a rat model of in situ single-pass perfusion
HUANG Hai-ying;GUO Yan-li;HE Yuan-song;WU Min-xuan;LI Jian;YU Ding-rong;SHI Jin-li;Beijing University of Chinese Medicine;Henan University of Chinese Medicine;Institute of Chinese Materia Medica;China Academy of Chinese Medical Science;

..............page:1108-1112

Preparation and accelerated release test of ropivacaine mesilate micropheres
ZHAO Xi-qing;LI Zhi-ping;ZHAO Shi-qing;LIU Yan;XIAO Ruo-lei;MEI Xing-guo;Pharmaceutical College of Hubei University of Science and Technology;Institute of Pharmacology and Toxicology;Academy of Military Medical Sciences;

..............page:1113-1118

Target identification of bioactive small molecules
WANG Dong-yao;CHEN Xiao-fei;CAO Yan;ZHU Zhen-yu;ZHANG Jun-ping;CHAI Yi-feng;School of Pharmacy;Second Military Medical University;

..............page:1119-1123

Advances in application of articular cavity microdialysis in pharmacokinetics and pharmacodynamics
SHAN Lian-ju;DING Han-ying;WANG Rui;LI Yong-ji;Heilongjiang University of Chinese Medicine;

..............page:1124-1127

A new cancer treatment strategy: combined drug therapy to simultaneously kill tumor cells and cancer stem cells
WANG Mei-ping;GONG Zhi-rong;ZHANG He;ZHONG Yan-qiang;LU Ying;Department of Pharmaceutical Sciences;School of Pharmacy;The Second Military Medical University;

..............page:1128-1133+1144

The role of pharmacokinetics in Beagle dogs for preclinical evaluation of extended-release formulations
YUAN Lin-wen;YANG Jin;Center of Drug Metabolism and Pharmacokinetics;China Pharmaceutical University;

..............page:1134-1140

Reporting of informed consent and ethics committee approval in clinical trials of antihypertensive drugs
ZHOU Yu-zi;ZHANG Ye-ping;GUO Ting-ting;GUO Xi-ying;WANG Zhen;LOU Ying;HUA Lu;LI Yi-shi;Key Laboratory of Clinical Trial Research in Cardiovascular Drugs;Ministry of Health;Fuwai Hospital;Chinese Academy of Medical Sciences and Peking Union Medical College;Civil Aviation General Hospital;

..............page:1141-1144

Strategies of the initiation and design of paediatric drug trials
LU Yao-wen;HE Yan-ling;CHENG Guo-hua;SUN Ming-jie;WANG Ting;Guangzhou Welman New Drug R&D Co.;Ltd.;Xiangbei Welman Pharmaceutical Co.;Ltd.;Guangzhou Women and Children’s Medical Center;School of Pharmacy;Jinan University;

..............page:1145-1149

Intentional attitude analysis for adverse drug event reporting of principal investigators in clinical trials
ZENG Ling-feng;LIU Jun;PAN Jian-ke;WANG Lu;WANG Ke-zhu;ZENG Xing;WANG Qi;Institute of Clinical Pharmacology;Guangzhou University of Chinese Medicine;Guangdong Provincial Hospital of Chinese Medicine;The 2nd School of Clinic Medicine of Guangzhou University of Chinese Medicine;Ethical Review Committee of World Federation of Chinese Medicine Societies;Institute of Medicinal Plant Development of Chinese Academy of Medical Sciences;

..............page:1150-1154+1159

A randomized study comparing the efficacy and safety of Shumian capsules and Jieyuanshen capsules in the treatment of insomnia
LIANG Ying;WANG Wei-dong;ZHANG Hong-yan;WANG Xing-chen;GU Wan-li;ZHAO Shi-ke;WEI Ming;Peking University Institute of Mental Health;Guang’anmen Hospital;China Academy of Chinese Medical Sciences;The Second Affiliated Hospital of Shandong University of TCM;Shandong Liaocheng City People’s Hospital;Shandong Jinan Hospital of Traditional Chinese Medicine;Shandong Binzhou Medical School Affiliated Hospital;

..............page:1155-1159

Relationship between EPIYA motif polymorphisms of Helicobacter pylori and gastroduodenal diseases in Chongqing
LIN Zhen;TIAN Zhi-ying;ZHU Li-li;TIAN Ling;ZHENG Jian;YANG Zhi-bang;Department of Laboratory Medicine;the Second Affiliated Hospital of Chongqing Medical University;Department of Pathogenic Biology;School of Basic Medical Sciences;Chongqing Medical University;Department of Infectious Disease;the Second Affiliated Hospital of Chongqing Medical University;

..............page:1160-1165+1170

Synthesis of impurities of the novel cholesterol-lowering drug candidate WS070117
ZHANG Wen-xuan;LI Bo;WU Hong-na;WANG Dong-mei;WU Song;Beijing City Key Laboratory of Active Substance Discovery and Druggability Evaluation;Institute of Materia Medica;Chinese Academy of Medical Sciences & Peking Union Medical College;

..............page:1166-1170

Construction and evaluation of HER2-targeted PAMAM dendrimer drug delivery system
MA Peng-kai;ZHANG Xue-mei;LI Jin-ming;NI Ling;WANG Zheng;ZHANG Feng-pu;SUN Kao-xiang;Pharmaceutical College of Yantai University;Shandong Luye Pharma Group;

..............page:1171-1177+1186

A general method for the determination of residual protein in fermented antibiotics
WANG Yan;YAO Shang-chen;CHANG Yan;CHONG Xiao-meng;MA Yue;HU Chang-qin;National Institute for Food and Drug Control;

..............page:1178-1186

Determination of ardisiacrispin B in Ardisia mamillata by HPLC-ELSD
GAO Jie;WU Hong;ZHANG Cheng-ping;ZHANG Qi;Southwest University for Nationalities;Sichuan Enwei Corporation of Traditional Chinese Medicine Research and Development;

..............page:1187-1190

Determination of N-methylmethanamine in metformin hydrochloride bulk drug using pre-column derivatization and RP-HPLC
FENG Chao;ZHANG You-yi;XU Xue;SUN Xiao-min;ZHANG Jun-ying;YAN Fang;FENG Fang;WU Chun-yong;Key Laboratory of Drug Quality Control and Pharmacovigilance;Ministry of Education;China Pharmaceutical University;Department of Pharmaceutical Analysis;China Pharmaceutical University;College of Health and Technology;Guangzhou Medical University;Department of Pharmaceutics of Traditional Chinese Medicine;China Pharmaceutical University;

..............page:1191-1196

Literature-based study of adverse effects of Yi-Qi-Fu-Mai sterile powder
MA Ning;HOU Ya-zhu;WANG Xian-liang;MAO Jing-yuan;Tianjin University of Traditional Chinese Medicine;The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine;

..............page:1197-1200